New and Generic Drug Approvals

New and Generic Drug Approvals

July 7, 2011

Amlodipine Besylate and Benazepril Hydrochloride Capsules, TEVA
Pharmaceuticals, Approval
Amlodipine Besylate and Benazepril Hydrochloride Capsules, Lupin Ltd., Approval
Amlodipine Besylate and Benazepril Hydrochloride Capsules, Mylan
Pharmaceuticals, Inc., Approval
Amlodipine Besylate and Benazepril Hydrochloride Capsules, Watson
Laboratories Inc., Approval
Amlodipine Besylate and Benazepril Hydrochloride Capsules, Dr. Reddy's
Laboratories Ltd., Approval
Coreg (carvedilol) Tablets, SmithKline Beecham, Labeling Revision
Coreg CR (carvedilol phosphate) Extended Release Capsules, SmithKline
Beecham, Labeling Revision
Duloxetine Hydrochloride Delayed Release Capsules, Wockhardt Ltd.,
Tentative Approval
Felbatol (felbamate) Tablets and Oral Suspension, Meda Pharmaceuticals
Inc., Labeling Revision
Kemadrin (procyclidine hydrochloride) Tablets, Monarch
Pharmaceuticals, Inc., Labeling Revision
Micardis (telmisartan) Tablets, Boehringer Ingelheim Pharmaceuticals,
Inc, Labeling Revision
Vancomycin Hydrochloride Injection, Pfizer Inc., Approval
Xenazine (tetrabenazine) Tablets, Valeant Pharmaceutical, Labeling Revision

Comentarios

Entradas populares de este blog

cómo diseñar un hospital veterinario by @esgdm

BD Unveils Nano Pen Needle for Accurate Subcutaneous Insulin Injections